Fine Mark National Bank & Trust Bristol Myers Squibb CO Transaction History
Fine Mark National Bank & Trust
- $2.7 Billion
- Q2 2024
A detailed history of Fine Mark National Bank & Trust transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 32,241 shares of BMY stock, worth $1.64 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
32,241
Previous 41,372
22.07%
Holding current value
$1.64 Million
Previous $2.24 Million
40.35%
% of portfolio
0.05%
Previous 0.09%
Shares
28 transactions
Others Institutions Holding BMY
# of Institutions
2,400Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.5 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.08 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.66 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.8 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.01 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $108B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...